Contract W81XWH18C0114

Spectral Md, Inc. · Department Of Defense · August 3, 2018

Small Business Set Aside - TotalFirm Fixed PriceFull & Open CompetitionNAICS 541715

Spectral Md, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on August 3, 2018 for $974,000 of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Dallas, TX. It was awarded under a small business set-aside. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 5, 2020.

Obligated to date
$974.5K
$974,465
Current value
$974.5K
Modifications
3
Latest August 5, 2020

Contract details

PIID
W81XWH18C0114
Award type
Definitive Contract
Pricing
Firm Fixed Price
Set-aside
Small Business Set Aside - Total
Competition
Full And Open Competition After Exclusion Of Sources
NAICS
541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
Product / service
R&D- Medical: Other (Basic Research)
Place of performance
Dallas, TX
First action
August 3, 2018
Latest action
August 5, 2020

Description

NO-COST EXTENSION, REVISED PROPOSAL INCORPORATION, AND CLAUSE AND LANGUAGE UPDATES TO THE AWARD OF SPECTRAL MD'S DHA STTR PHASE II MEDICAL R&D CONTRACT FOR "MEDICAL DEVICE TO ASSESS THE VIABILITY OF T

Modification timeline

  • August 5, 2020
    Mod P00003
    NO-COST EXTENSION, REVISED PROPOSAL INCORPORATION, AND CLAUSE AND LANGUAGE UPDATES TO THE AWARD OF SPECTRAL MD'S DHA STTR PHASE II MEDICAL R&D CONTRACT FOR "MED
    $0
  • August 14, 2019
    Mod P00002
    INCREMENTAL FUNDING FOR SPECTRAL MD'S DHA STTR PHASE II MEDICAL R&D CONTRACT FOR "MEDICAL DEVICE TO ASSESS THE VIABILITY OF TISSUE PRIOR TO SKIN GRAFTING"
    $350.8K
  • March 25, 2019
    Mod P00001
    COR CHANGE AND ADDITION OF FUNDAMENTAL RESEARCH LANGUAGE TO SPECTRAL MD'S DHA 17.A STTR MEDICAL R&D CONTRACT FOR "MEDICAL DEVICE TO ASSESS THE VIABILITY OF TISS
    $0
  • August 3, 2018
    Base award
    AWARD OF DHA 17.A(A) STTR PHASE II R&D MEDICAL CONTRACT TO SPECTRAL MD, INC. IAW FOR PROPOSAL H2-0337 FOR "MEDICAL DEVICE TO ASSESS THE VIABILITY OF TISSUE PRIO
    $623.7K

Similar contracts

RecipientAgencyDateObligated
Trenchant Analytics LlcDepartment Of DefenseDecember 31, 2025$250.0K
Viasat IncDepartment Of DefenseDecember 31, 2025$3.69M
Gemini Technical Services Jv, LlcDepartment Of DefenseDecember 31, 2025$5.84M
Ursa IncDepartment Of DefenseDecember 31, 2025$340.0K
The Johns Hopkins University Applied Physics Laboratory LlcDepartment Of DefenseDecember 31, 2025$5.68M
L3harris Forcex, Inc.Department Of DefenseDecember 31, 2025$2.39M

Top contractors in NAICS 541715

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract W81XWH18C0114?

Contract W81XWH18C0114 is a federal contract awarded to Spectral Md, Inc. by Department Of Defense on August 3, 2018 for $974,000 of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 3 times since the base award.

Who won contract W81XWH18C0114?

Spectral Md, Inc. won contract W81XWH18C0114 from Department Of Defense.

How much is contract W81XWH18C0114 worth?

Contract W81XWH18C0114 has obligated $974,000 to date.